Would you give abiraterone in the post-prostatectomy setting to patients with positive nodes detected at surgery?

Topics: Radiation Oncology • Genitourinary Cancers • Prostate Cancer • Medical Oncology

Is there data and FDA approval for this indication?

What about for nodal failure after radiation?

Answer from: Medical Oncologist at Academic Institution

This clinical scenario of N1 but resected disease post-RP represents an area where there is not sufficient evidence to recommend abiraterone or any potent AR inhibitor. While there is evidence to support ADT in this adjuvant setting for N1 resected patients based on the older Messing ECOG trial, sim...

Comments

Radiation Oncologist at Lafayette Radiation Center
What about in the setting of adjuvant radiation fo...

Related Questions